VJET Flyte Aviation, Inc.
Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1716621 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY599.8%
TTM net income YoY-51.9%
TTM EPS YoY89.8%
Revenue 3-yr CAGR124.0%
Net income 3-yr CAGR—
Margins
Gross margin29.2%
Operating margin-527.1%
Net margin-733.4%
FCF margin-331.6%
EBITDA margin-499.9%
Returns
ROE-273.6%
ROA-104.1%
ROIC (approx.)-173.4%
Asset turnover0.14x
Leverage & solvency
Liabilities / assets51.7%
Debt / equity0.00x
Current ratio0.54x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-57.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.84M | $1.02M | $432,000 | $238,000 | $0 | $212,000 | $143,000 | $149,000 |
| Cost of revenue | $1.51M | $921,000 | $42,000 | $20,000 | $0 | $14,000 | $11,000 | $11,000 |
| Gross profit | $324,000 | $98,000 | $390,000 | $218,000 | $0 | $198,000 | $132,000 | $138,000 |
| R&D expense | $0 | $142,000 | $149,000 | $328,000 | $0 | $155,000 | $103,000 | $91,000 |
| SG&A expense | $2.78M | $3.91M | $2.56M | $2.76M | $1.19M | $2.88M | $3.48M | $3.10M |
| Operating income | -$2.46M | -$3.96M | -$2.32M | -$9.86M | -$1.19M | -$4.69M | -$3.58M | -$3.05M |
| Pretax income | -$2.32M | -$3.62M | -$1.86M | -$6.06M | -$1.16M | -$6.41M | -$4.77M | -$2.49M |
| Income tax | -$463,000 | -$312,000 | -$175,000 | -$214,000 | $78,000 | -$950,000 | -$724,000 | $3.14M |
| Net income | -$15.11M | -$3.29M | -$1.68M | -$5.78M | -$2.25M | -$5.11M | -$4.04M | -$5.63M |
| EBITDA | -$2.45M | -$3.93M | -$1.91M | -$9.33M | -$1.19M | -$4.67M | -$3.04M | -$2.52M |
| EPS (basic) | -8.16 | -0.92 | -1.39 | — | -17.05 | -7.28 | -6.81 | — |
| EPS (diluted) | -7.72 | — | — | — | -17.05 | — | — | — |
| Weighted avg. shares (diluted) | 1.96M | — | — | — | 132,054 | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.39M | $643,000 | $441,000 | $88,000 | $1.07M | $838,000 | $450,000 | $2.87M |
| Short-term investments | — | $1.20M | — | $0 | — | — | — | — |
| Receivables | $160,000 | $120,000 | $261,000 | $155,000 | $123,000 | $115,000 | $85,000 | $70,000 |
| Inventory | — | $88,000 | $62,000 | $86,000 | $34,000 | $48,000 | $71,000 | $33,000 |
| Current assets | $3.82M | $2.51M | $1.25M | $390,000 | $2.47M | $2.05M | $854,000 | $3.29M |
| PP&E, net | $141,000 | $128,000 | $129,000 | $0 | $72,000 | $79,000 | $93,000 | $91,000 |
| Goodwill | $12.16M | $12.96M | $9.72M | $0 | — | — | — | — |
| Intangibles | $4.04M | $18.60M | $22.30M | $0 | $22.74M | $23.25M | $23.76M | $24.27M |
| Total assets | $24.23M | $36.87M | $35.09M | $15.86M | $25.47M | $25.56M | $24.80M | $27.77M |
| Current liabilities | $7.06M | $13.45M | $19.74M | $3.91M | $5.33M | $4.64M | $4.09M | $2.23M |
| Short-term debt | — | — | $6.54M | $0 | — | — | — | — |
| Long-term debt | — | — | — | $3.08M | $1.50M | $1.50M | — | — |
| Total debt | — | — | — | $3.08M | $1.50M | $1.50M | — | — |
| Total liabilities | $12.54M | $19.73M | $25.93M | $9.21M | $19.02M | $19.01M | $16.88M | $16.01M |
| Shareholders' equity | $12.12M | $17.56M | $9.57M | $7.05M | $6.78M | $6.79M | $7.92M | $11.76M |
| Net debt | — | — | — | $2.99M | $425,000 | $662,000 | — | — |
| Shares outstanding | 2.10M | 3.61M | 2.69M | 173,896 | 1.65M | 18.86M | 9.27M | 421,296 |
| Cash flow statement | ||||||||
| Operating cash flow | -$4.50M | -$2.86M | -$2.80M | -$1.51M | -$2.18M | -$2.26M | -$2.34M | -$2.86M |
| Capital expenditure | $5,000 | $15,000 | $6,000 | $0 | $0 | $7,000 | $10,000 | $0 |
| Free cash flow | -$4.50M | -$2.88M | -$2.80M | -$1.51M | -$2.18M | -$2.27M | -$2.35M | -$2.86M |
| Investing cash flow | $1.28M | -$833,000 | -$1.32M | $218,000 | -$28,000 | -$13,000 | -$10,000 | $0 |
| Financing cash flow | $4.96M | $3.90M | $4.47M | $307,000 | $2.45M | $2.66M | -$75,000 | $4.47M |
| Depreciation & amortization | $4,000 | $21,000 | $405,000 | $527,000 | $1,000 | $18,000 | $531,000 | $531,000 |
| Stock-based compensation | $161,000 | $266,000 | $64,000 | $79,000 | $70,000 | $98,000 | $91,000 | $18,000 |
Free plan shows the latest 8 periods; Pro shows all 37 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.